Skip to content

IMPACT: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

IMPACT

BE 0429.628.737
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2023 against 2024filed annual accounts (NBB)
Net result for the year
€489,078
2023 · €300,540+€188,538
Equity
€1.1m
2023 · €684,260+€449,078
Cash
€693,574
2023 · €345,126+€348,447
Balance sheet total
€1.4m
2023 · €1.0m+€442,038

Largest movements

2023 to 2024
Assets
  • Cash +€348,447

    up €348,447 (+101.0%), from €345,126 to €693,574

    mainly Net result for the year (+€489,078) and Depreciation (+€33,470)

  • Receivables within one year +€105,361

    up €105,361 (+21.4%), from €492,423 to €597,784

    of which Trade receivables: +€114,741

  • Tangible fixed assets -€19,758

    down €19,758 (-22.4%), from €88,053 to €68,295

Equity and liabilities
  • Reserves +€370,500

    up €370,500 (+61.7%), from €600,479 to €970,979

    of which Distributable reserves: +€282,090

  • Profit (loss) carried forward +€78,578

    up €78,578 (+101.3%), from €77,584 to €156,162

  • Tax, wage and social debts +€21,007

    up €21,007 (+23.6%), from €89,122 to €110,130

    of which Taxes: +€10,586

  • Other debts -€16,000

    down €16,000 (-15.1%), from €106,000 to €90,000

Income statement
  • Gross operating margin +€330,205

    up €330,205 (+55.3%), from €597,298 to €927,502

  • Taxes +€75,160

    up €75,160 (+61.4%), from €122,471 to €197,631

  • Staff costs +€66,554

    up €66,554 (+45.0%), from €147,823 to €214,377

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 €300,540
Gross operating margin +€330,205
Staff costs -€66,554
Depreciation +€169
Other operating charges +€62
Financial income +€2,930
Financial charges -€3,113
Taxes -€75,160
Result 2024 €489,078

Cash bridge derived

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€411,314
Investment -€13,712
Financing -€49,154
Cash 2023 €345,126
Net result for the year +€489,078
Depreciation +€33,470
Stocks and contracts -€5,001
Receivables within one year -€105,361
Deferred charges and accrued income -€2,987
Trade debts -€269
Tax, wage and social debts +€21,007
Other debts -€16,000
Accrued charges and deferred income -€2,624
Investment in fixed assets (net) -€13,712
Debts after one year -€6,169
Current portion of long-term debt -€2,986
Contributions, distributions and other -€40,000
Cash 2024 €693,574
Every line side by side 48 lines
Line Code 2023 2024 Change %
Total assets 20/58 €1,001,061 €1,443,099 +€442,038 +44.2%
Fixed assets 21/28 €91,038 €71,280 -€19,758 -21.7%
Tangible fixed assets 22/27 €88,053 €68,295 -€19,758 -22.4%
Furniture and vehicles 24 €88,053 €68,295 -€19,758 -22.4%
Financial fixed assets 28 €2,985 €2,985 = 0.0%
Current assets 29/58 €910,023 €1,371,819 +€461,796 +50.7%
Stocks and contracts in progress 3 €68,268 €73,269 +€5,001 +7.3%
Stocks 30/36 €68,268 €73,269 +€5,001 +7.3%
Amounts receivable within one year 40/41 €492,423 €597,784 +€105,361 +21.4%
Trade receivables 40 €396,554 €511,294 +€114,741 +28.9%
Other amounts receivable 41 €95,870 €86,490 -€9,380 -9.8%
Cash at bank and in hand 54/58 €345,126 €693,574 +€348,447 +101.0%
Deferred charges and accrued income 490/1 €4,205 €7,191 +€2,987 +71.0%
Total equity and liabilities 10/49 €1,001,061 €1,443,099 +€442,038 +44.2%
Equity 10/15 €684,260 €1,133,338 +€449,078 +65.6%
Contributions 10/11 €6,197 €6,197 = 0.0%
Reserves 13 €600,479 €970,979 +€370,500 +61.7%
Tax-exempt reserves 132 €258,620 €347,030 +€88,410 +34.2%
Distributable reserves 133 €341,859 €623,949 +€282,090 +82.5%
Profit (loss) carried forward 14 €77,584 €156,162 +€78,578 +101.3%
Amounts payable 17/49 €316,801 €309,760 -€7,040 -2.2%
Amounts payable after more than one year 17 €6,169 - -€6,169
Financial debts 170/4 €6,169 - -€6,169
Amounts payable within one year 42/48 €308,008 €309,760 +€1,752 +0.6%
Current portion of amounts payable after more than one year 42 €9,154 €6,169 -€2,986 -32.6%
Trade debts 44 €103,731 €103,462 -€269 -0.3%
Suppliers 440/4 €103,731 €103,462 -€269 -0.3%
Taxes, remuneration and social security 45 €89,122 €110,130 +€21,007 +23.6%
Taxes 450/3 €70,122 €80,708 +€10,586 +15.1%
Remuneration and social security 454/9 €19,000 €29,421 +€10,421 +54.8%
Other amounts payable 47/48 €106,000 €90,000 -€16,000 -15.1%
Accrued charges and deferred income 492/3 €2,624 - -€2,624
Non-recurring operating income 76A €47 €1,342 +€1,294 +2726.0%
Remuneration, social security and pensions 62 €147,823 €214,377 +€66,554 +45.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €33,639 €33,470 -€169 -0.5%
Other operating charges 640/8 €7,473 €7,411 -€62 -0.8%
Gross operating margin 9900 €597,298 €927,502 +€330,205 +55.3%
Operating profit (loss) 9901 €408,363 €672,244 +€263,881 +64.6%
Financial income 75/76B €17,512 €20,441 +€2,930 +16.7%
Recurring financial income 75 €17,512 €20,441 +€2,930 +16.7%
Financial charges 65/66B €2,864 €5,976 +€3,113 +108.7%
Recurring financial charges 65 €2,864 €5,976 +€3,113 +108.7%
Profit (loss) for the period before taxes 9903 €423,011 €686,709 +€263,698 +62.3%
Income taxes 67/77 €122,471 €197,631 +€75,160 +61.4%
Profit (loss) for the period 9904 €300,540 €489,078 +€188,538 +62.7%
Transfer from tax-exempt reserves 789 - €122,090 +€122,090
Transfer to tax-exempt reserves 689 €63,150 €210,500 +€147,350 +233.3%
Profit (loss) for the period to be appropriated 9905 €237,390 €400,668 +€163,278 +68.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.